Furthermore, Western blotting analysis demonstrated that in the 15/30 glioma samples with SLC22A18 promoter methylation, SLC22A18 protein expression was significantly decreased compared to the adjacent normal brain tissue (Figure 3C). Here, SLC67A1 is linked to glioma.